Corcept Therapeutics Incorporated shares owned by Smith Group Asset Management
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Smith Group Asset Management
from 13F filings
Historical chart of Smith Group Asset Management investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Smith Group Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Smith Group Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $773k | 9.3k | 83.11 |
| 2025-06-30 | $662k | 9.0k | 73.40 |
| 2025-03-31 | $1.0M | 9.0k | 114.22 |
| 2024-12-31 | $776k | 15k | 50.39 |
| 2024-09-30 | $706k | 15k | 46.28 |
| 2024-06-30 | $396k | 12k | 32.49 |
| 2024-03-31 | $305k | 12k | 25.19 |
| 2023-12-31 | $393k | 12k | 32.48 |
| 2021-09-30 | $540k | 27k | 19.69 |
More positions owned by Smith Group Asset Management
View all positions for Smith Group Asset Management
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated